This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cardiac Surgery
and you are
between 18 and 85
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study aims to examine the efficacy of levosimendan in terms of reducing postoperative mortality and severe morbidity in patients undergoing non-emergent surgery for coronary revascularisation with or without ischaemic mitral regurgitation and who may or may not require repair or replacement of the mitral valve and have a LVEF < 35%.

Provided treatments

  • Drug: Levosimendan
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01595737. The sponsor of the trial is Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau and it is looking for 30 volunteers for the current phase.
Official trial title:
Comparison of the Administration of Levosimendan and Placebo in the Preparation of Critical Patients for Heart Surgery